CD9-binding peptide

CD9-binding peptide is a CD9-binding peptide. CD9-binding peptide inhibits the binding of EWI-2 to CD9. CD9-binding peptide exhibits selective anti-migratory and anti-invasive activities against cancer cells. CD9-binding peptide can be used for the study of cancer[1].

Product Specifications

CAS Number

[2843551-32-4]

UNSPSC

12352209

Target

Others

Related Pathways

Others

Applications

Cancer-programmed cell death

Field of Research

Cancer

Smiles

OC([C@H](CC1=CN=CN1)NC([C@H](CC(C)C)NC([C@H](CCCNC(N)=N)NC([C@H](CC(C)C)NC([C@H](CCCNC(N)=N)NC([C@@H](NC([C@H](CO)NC([C@@H](N)CCCNC(N)=N)=O)=O)CC2=CN=CN2)=O)=O)=O)=O)=O)=O

Molecular Formula

C45H79N21O10

Molecular Weight

1074.24

References & Citations

[1]Suwatthanarak T, et al. Inhibition of cancer-cell migration by tetraspanin CD9-binding peptide. Chem Commun (Camb) . 2021 May 18;57 (40) :4906-4909.